Jennifer Grace Abelin

Title: Innovations of Jennifer Grace Abelin

Introduction

Jennifer Grace Abelin is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of HLA-based methods and compositions. With a total of 3 patents, her work has the potential to impact various applications in medical research and treatment.

Latest Patents

Abelin's latest patents include innovative systems, compositions, and methods for isolating HLA-peptides from cells. One of her notable inventions is a universal platform and methods for profiling the HLA-peptidome. This technology enables the identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct. Additionally, she has developed compositions and methods for isolating HLA-peptides from cells, further enhancing the capabilities of her research.

Career Highlights

Jennifer Grace Abelin is currently associated with BioNTech US Inc., where she continues to advance her research and innovations. Her work is recognized for its potential to revolutionize the understanding of immune responses and therapeutic strategies.

Collaborations

Some of her notable coworkers include Michael Steven Rooney and Dominik Barthelme, who contribute to her research endeavors and collaborative projects.

Conclusion

Jennifer Grace Abelin's contributions to biotechnology through her patents and research at BioNTech US Inc. highlight her role as an influential inventor in the field. Her innovative approaches to HLA-peptide profiling are paving the way for advancements in medical science.